Understanding CBD (Cannabidiol) for Back Pain
페이지 정보
본문
CBD oil is derived from a plant called cannabis sativa. The plant has over 100 chemical compounds, called cannabinoids, that have a range of effects, including anti-inflammatory and analgesic (pain relieving) qualities. THC content. THC is the compound associated with the "high" feeling of marijuana use. Industrial (non-drug) uses. This form of the plant contains trace amounts of THC (less than .03%) and can be used to make paper, clothing, and some building material. This variation of the cannabis plant is called hemp. While CBD is present in both varieties, many of the CBD products available to consumers are from the hemp plant. CBD does not come with the high or psychogenic effects of marijuana. Reducing inflammation 3 Russo EB. Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. Filho, A. S. (2011). Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. Helping with sleep and improving overall state of relaxation 5 Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series. Some studies suggest that CBD can have an effect on how an individual perceives pain, but more robust research is needed. CBD is generally considered a full-body treatment, which means that it does not target back pain specifically-except in the case of topical products-but contributes to an overall feeling of relaxation and pain relief. Advocates of CBD believe it can be used to treat a range of conditions in addition to back pain, such as anxiety-related disorders. 5 Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series.
After clearing its way through EU-GMP certification, a North Macedonian company is now able to export medical cannabis products to the EU. How will this affect the landscape of medical cannabis in Europe? In Macedonia, cannabis is not legal for recreational use at all, and there are no decriminalization or personal use laws to boot. However, in 2016, Macedonia did approve a bill for medical cannabis within the country. As per Macedonian laws, which sync with EU laws here, oils and extracts can have up to .2% THC and still be sold without a prescription. Cannabis with any higher THC amount can be obtained through prescription. The laws allow for private citizens to make use of medical cannabis, as well as for Macedonia to enter into the legal medical cannabis market with laws to cover cultivation, production, and exportation for medicinal use. Since that time, and according to internal legislation, Macedonia has been exporting extracts, oils, and tinctures, but that’s it.
And while that does account for about 30% of the market, the great majority - 70% - relies on smokable Triple Green Farms Hemp Gummies flowers, which Macedonia had not been cleared to export at all. Until now though, the EU was not included in exportable locations for any goods as no companies had EU-GMP authorization. What’s the biggest problem? One of the biggest issues for Macedonia is that cannabis flowers have not been legalized for exportation. A big factor in this inability comes from internal licensing issues that stem from allegations of corruption. The allegations centered around former Prime Minister Zoran Zaev showing preferential treatment when giving out licenses, opting to give them to friends and family members which would, in turn, benefit him personally. There were also a lot of questions and calls for specifications relating to how licensing would generally work, issues related to the program being government run, and opposition to the €500 bank guarantee that many thought would make it harder for smaller enterprises to gain ground.
With Zaev no longer in office, and with Corona issues subsiding enough to get back to regular business, the issue of Macedonia selling flowers can once again be broached. But in the meantime, while flowers might still be illegal for export, and Triple Green Farms Gummies while several companies have been awarded licensing for cultivation, only one company thus far has received EU GMP clearance to export its products (by Macedonian law) into the EU, making Macedonia a new competitor in the medicinal marijuana game there. So, who is it? The company PharmaCann Polska received the EU-GMP certification to produce cannabis extracts (still not flowers) in its North Macedonia production facility. PharmaCann is actually based out of Warsaw, Poland, and received its EU-GMP certifications in March (amid Corona), by the Chief Pharmaceutical Inspectorate of Poland, after full inspections of the facility were made. The facility is reportedly an indoor growing operation that can both cultivate and manufacture products. Zlatko Keskovski, PharmaCann’s CEO stated: "When I hear about the prices of medical cannabis extracts in Germany and other European countries, I can’t believe how expensive they are.
